The stool is where the answer lives because that is where the unabsorbed fat ends up. One test measures a pancreatic enzyme that survives the trip through the intestine. Another measures how much fat is actually lost over several days. Neither names a disease on its own, and both give a clinician something concrete to work with.
Stool fat is the fraction of dietary fat that was never broken down and absorbed in the small intestine, plus a small background amount from shed intestinal cells and gut bacteria. Everyone passes some. The question is always how much, not whether.
Fat absorption depends on a short chain of steps that all have to work. Fat arrives in the duodenum in large droplets. Bile salts from the liver and gallbladder emulsify those droplets into something enzymes can reach. Pancreatic enzymes, lipase above all, split triglycerides into fatty acids and monoglycerides. Those products form micelles, and the lining of the jejunum takes them up. Break any link in that chain, whether it is enzyme output, bile delivery, mixing, or the absorptive surface itself, and fat carries on down the tract instead of entering the body.
Quantitative testing puts a number on the loss. On a defined fat intake, laboratories commonly regard fat excretion above roughly 7 grams per day as steatorrhea, and this timed collection remains the reference method against which simpler tests are compared 1. Below that threshold, a modest amount of fat in stool is expected and means nothing by itself.
What people notice at home is cruder than a laboratory number. Stools that are pale or clay coloured, unusually bulky, oily on the water surface, foul smelling in a way that is clearly different from normal, or that leave a greasy film, are the pattern worth taking seriously. Floating alone is a weak sign, because gas floats stool just as readily as fat does.
Fat loss matters because fat carries both energy and four vitamins the body cannot absorb any other way. When fat is not absorbed, calories leave with it, and vitamins A, D, E and K leave with it too.
That is why the downstream consequences often show up far from the gut. Unintentional weight loss and muscle loss come from the energy deficit. Low vitamin D affects bone, low vitamin A affects vision in dim light and skin integrity, low vitamin E affects nerve and muscle function over long periods, and low vitamin K affects clotting. Pancreatic exocrine insufficiency is associated with deficiencies in fat soluble vitamins and with broader markers of undernutrition such as low circulating proteins and low bone mineral density 2. Checking fat soluble vitamin status alongside the stool test may help a clinician judge how much absorption has actually been lost, which is why guidelines recommend monitoring nutritional parameters rather than symptoms alone 3.
There is also a quieter version of the problem. Fat loss can be real without being dramatic. Someone may have slightly loose stools, bloating after richer meals, and a slow drift downward in weight or in vitamin D, with nothing in the toilet bowl that looks obviously abnormal. That is the presentation most often missed, and it is the reason a laboratory measure is more useful than a visual impression.
The practical meaning is simple. Fat in stool is not a cosmetic issue about stool appearance. It is a measurable loss of energy and micronutrients, and it tends to compound quietly over months.
Fat globules in stool are what a laboratory sees when it puts a smear of stool under a microscope and stains it with a fat specific dye. The report usually describes the number of globules per field as few, moderate or many, which makes it a screening observation rather than a measurement.
Two kinds of fat can be reported. Neutral fat globules are intact triglyceride droplets that were never split, which points toward a problem with the enzymes doing the splitting. Split fats, seen as fatty acid crystals or soaps, suggest the fat was broken down but not taken up across the intestinal lining. In practice the distinction is less clean than textbooks imply, because sample handling, how recently the person ate, and the reader's judgement all influence what appears on the slide.
So a report of stool fat globules is best read as a prompt, not a verdict. Many globules in someone with greasy stools and weight loss is a strong reason to go further. A few globules in someone with no symptoms may mean very little. A negative stain does not rule out mild fat malabsorption, because the method is not sensitive enough to catch small losses.
The next step after a positive microscopic result is usually a test that measures something specific, either pancreatic elastase 1 in a single stool sample or quantified fat over a timed collection. The globules tell you to keep looking. They do not tell you where the problem sits.
Pancreatic elastase 1 is a digestive enzyme made by the acinar cells of the pancreas, and it is unusual in that it passes through the intestine almost intact. Because it is not degraded on the way, its concentration in a stool sample tracks how much enzyme the pancreas is releasing into the gut.
That durability is what makes the test practical. Measuring pancreatic output directly requires intubating the duodenum and collecting secretions, which is accurate but invasive and available in few places. A fecal elastase test needs one stool sample, no special diet, and no timed collection. Guidelines recommend fecal elastase 1 as the first line test when exocrine pancreatic insufficiency is suspected, precisely because it is non invasive and widely available 3.
The trade off is sensitivity at the mild end. Fecal elastase falls reliably once enzyme output has dropped a long way, which means it performs best in moderate to severe insufficiency and can read normal when the loss is early or partial 1. A normal elastase in someone with convincing symptoms therefore does not close the question.
It is also worth being clear about what the test does not measure. Elastase reflects enzyme output, not fat absorption. A person can have low elastase and still absorb fat reasonably well, and a person can lose fat through the stool for reasons that have nothing to do with the pancreas. The two measurements answer different questions, and clinicians often use them together.
Most reports fall into recognisable bands, and the bands are interpretive thresholds rather than tidy reference intervals. The table below shows what laboratories typically report and how those results are generally regarded.
| Test | Typical result band | What laboratories generally regard it as |
|---|---|---|
| Fecal elastase 1 | Above 200 µg/g stool | Normal exocrine pancreatic function |
| Fecal elastase 1 | 100 to 200 µg/g stool | Mild to moderate reduction, often reported as indeterminate |
| Fecal elastase 1 | Below 100 µg/g stool | Severe reduction in enzyme output |
| Quantitative fecal fat, timed collection | Below roughly 7 g of fat per day on a defined fat intake | Normal fat absorption |
| Qualitative fat stain, microscopy | Few or no fat globules per field | Negative screen for fat malabsorption |
These are typical laboratory reference bands, and they vary by laboratory, assay and population, with age and sex influencing some of them. They are interpretive thresholds, not diagnoses.
The indeterminate band is the one that causes the most confusion. A result between 100 and 200 µg/g is genuinely ambiguous, and a watery sample can push a normal pancreas into that range without any pancreatic problem at all. Clinicians commonly repeat the test on a formed sample, look at the clinical picture, and check nutritional markers before deciding what the number means.
Read any result the same way. Note what the value shows, consider what it may reflect given the symptoms and history around it, and take it to a clinician who can decide whether further testing is warranted. A single number, on its own, names nothing.
A low fecal elastase result reflects reduced delivery of pancreatic enzymes into the intestine, and the reasons for that fall into a short list worth knowing.
Damage to the gland itself is the classic cause. Chronic pancreatitis progressively destroys acinar tissue, and steatorrhea tends to appear late in that process, after a large proportion of enzyme secreting capacity has already been lost 4. Pancreatic surgery removes functioning tissue directly. Obstruction of the pancreatic duct, from any cause, blocks enzymes from reaching the duodenum even when the gland is still producing them. Cystic fibrosis affects enzyme secretion from early life.
Surgery elsewhere in the upper digestive tract matters more than most people expect. A meta-analysis found that pancreatic exocrine insufficiency is common after non-pancreatic upper gastrointestinal surgery, including operations on the stomach and oesophagus 5. The mechanism is less about gland damage and more about disrupted timing and mixing, where food and enzymes no longer meet in the right place at the right moment.
Lower levels also turn up in people with long standing diabetes, in people with coeliac disease, and in some inflammatory bowel conditions, where reduced hormonal stimulation of the pancreas appears to play a part.
The practical reading is this. A low result identifies a pattern, not a cause. What follows is usually a conversation about history, risk factors and imaging, and the decision about what to do next belongs to a clinician who can see the whole picture.
Plenty of things other than the pancreas, which is exactly why the symptom alone is a poor guide. Fat needs bile and a healthy absorptive surface as much as it needs enzymes.
Bile is the first alternative. If bile flow is reduced or diverted, fat is never properly emulsified, and the result in the toilet bowl looks much the same as enzyme failure. Conditions affecting the liver, bile ducts or gallbladder can produce pale, greasy stools for this reason. Separately, bile acid malabsorption produces urgent watery diarrhoea that is often mistaken for fat loss.
The intestinal lining is the second. Coeliac disease, after a long period undiagnosed, flattens the absorptive surface. Crohn's disease, previous small bowel resection, and small intestinal bacterial overgrowth all reduce the surface available or interfere with bile salt function.
Then there is overlap with common functional conditions. Research suggests that symptom patterns alone do not reliably separate irritable bowel syndrome with diarrhoea from organic causes including exocrine pancreatic insufficiency, which is why structured testing is recommended rather than diagnosis by symptom profile 6.
Finally, the mundane explanations. A very high fat meal, certain sugar substitutes, and some over the counter products that reduce fat absorption all change stool appearance temporarily. A single greasy stool after an unusual meal is not a finding. A persistent pattern over weeks is.
It depends which test is ordered, and the two differ enormously in what they ask of the person being tested.
A fecal elastase 1 test needs one stool sample. No dietary preparation is required, the sample should ideally be formed rather than watery, and it goes into a standard collection container supplied by the laboratory. Samples are generally kept cool and returned promptly, because the laboratory's handling instructions exist to keep the measurement stable. This is the test most people encounter, and it is the one that can be done at home.
Quantitative fecal fat is a different proposition. It requires eating a defined amount of fat each day for a set period, then collecting every stool passed over a timed window, usually three days, so the laboratory can measure total fat output and calculate how much of the ingested fat was absorbed. It is accurate and it is unpopular, both for the person collecting and for the laboratory processing it, and it is used far less often than the simpler alternative 1.
The qualitative fat stain sits in between. It needs only a small sample and a microscope, and gives an impression rather than a measurement.
In ordinary practice, the sequence tends to run from the easy test to the demanding one. A single sample elastase result, read alongside symptoms and blood markers, resolves most questions. Timed fat collection is reserved for cases where the picture stays unclear or where the degree of fat loss needs quantifying.
Several things, and most of them are avoidable once you know about them.
Stool consistency is the biggest. Watery stool dilutes elastase, which can drive a result into the low range in someone whose pancreas is working normally, so a formed sample matters and a borderline result on a loose sample is often repeated 7. The same applies in reverse. Elastase concentration can look reassuring in a very dry sample.
Assay type matters too. Monoclonal assays measure human pancreatic elastase specifically, so enzyme therapy taken by mouth does not inflate the result, and guidelines note that the test can therefore be performed without interrupting such therapy 3. Where treatment of any kind is involved, those decisions belong to a licensed provider.
Sensitivity at the mild end is a limitation rather than an error. Because elastase falls meaningfully only once enzyme output has dropped substantially, early or partial insufficiency can produce a normal number 1. A normal result in someone with persistent fatty stools, weight loss, or falling fat soluble vitamin levels is worth revisiting rather than filing away.
For timed fat collection, the usual failures are practical. An incomplete collection or an inconsistent fat intake during the collection period makes the calculated figure unreliable, which is why laboratories give precise written instructions for both.
Blood markers answer the question the stool test cannot, which is whether the fat loss has already cost the body something measurable. Stool tells you about the process. Blood tells you about the consequences.
The fat soluble vitamins come first. Vitamin D is the one most often already on file, and it is the one most likely to be low. Vitamin A and vitamin E are measured less routinely but are directly relevant when fat absorption is in question. Vitamin K status is usually inferred from clotting measures rather than measured directly. Guidelines recommend assessing nutritional status, including fat soluble vitamins, in people with suspected or confirmed exocrine pancreatic insufficiency rather than relying on symptoms to judge severity 3.
Beyond the vitamins, several markers round out the picture. Albumin and prealbumin reflect protein status. Magnesium, zinc, ferritin and vitamin B12 catch deficiencies that often travel with malabsorption. HbA1c matters because the pancreas does two jobs, and loss of the enzyme producing tissue can sit alongside changes in blood sugar regulation. Lipid levels sometimes drift downward when fat absorption falls. Coeliac serology is commonly checked because coeliac disease is a frequent alternative explanation.
This is the kind of question a broad panel handles better than a single test. Atlas, FitScript's AI health advisor, reads markers like these together rather than one at a time, across the 150+ biomarkers tested per year that members have on file, and flags the patterns worth raising with a clinician.
Blood lipase is a different measurement from anything in stool. It reflects enzyme spilling from the pancreas into the bloodstream, which is why it rises sharply in acute inflammation of the gland, and it is not a measure of how well fat is being digested. In long standing loss of pancreatic tissue, blood lipase can be normal or even low while fat is clearly being lost in stool.
FitScript's optimal range for Lipase is 10 to 45 U/L, against a typical laboratory reference range of 0 to 60 U/L. Optimal ranges are FitScript's optimization targets, not diagnostic cut-offs.
The linked guide covers what the marker measures, how it is tested and how to read a result in detail. For the purposes of this page, the point is that a normal lipase does not rule out fat malabsorption, and an abnormal one asks a different question entirely.
The combination of greasy stools and unintentional weight loss is the pattern that most deserves attention, because it suggests the fat loss is large enough to create an energy deficit rather than just a change in stool appearance.
Here is the sequence worth walking through. The observation is weight falling without a deliberate change in eating or activity, together with stools that are bulky, pale or oily. What it may reflect is that a meaningful share of dietary fat, and the calories it carries, is leaving the body unabsorbed. In chronic pancreatitis, this stage typically arrives only after extensive loss of enzyme secreting tissue, which is why visible steatorrhea is considered a late feature rather than an early warning 4. Alongside the energy loss, fat soluble vitamin status and body composition often deteriorate together 2.
The next step is a clinician, and reasonably soon. Weight loss with fatty stools is worth discussing with a clinician promptly, because the useful work is in finding the cause, and several of the possible causes benefit from being identified early.
What is not useful is self experimentation. Cutting fat from meals may make the stools look better while leaving the underlying absorption problem untouched and the vitamin deficits deepening. The appearance improves. The situation does not.
Testing is usually prompted either by symptoms or by a history that raises the prior probability, and a few groups come up repeatedly.
People with chronic diarrhoea that has not resolved are the largest group, particularly where a functional diagnosis has been assumed but never confirmed. Structured evaluation is recommended in chronic diarrhoea precisely because exocrine pancreatic insufficiency hides inside that symptom pattern 6. People with known pancreatic disease, including previous episodes of pancreatitis or confirmed chronic pancreatitis, are followed because enzyme output declines over time 4.
Anyone who has had upper gastrointestinal surgery is a candidate, and this group is under-tested relative to the risk. Studies indicate that pancreatic exocrine insufficiency occurs frequently after upper gastrointestinal operations that do not involve the pancreas itself 5. People with cystic fibrosis are screened as part of routine care. People with long standing diabetes, coeliac disease or inflammatory bowel disease are sometimes tested when symptoms or nutritional markers suggest it.
There is also a group that arrives from the other direction, through their bloodwork. A persistently low vitamin D that does not respond as expected, a low vitamin A or vitamin E, or a slow unexplained decline in weight or lean mass can all lead a clinician to look at digestion rather than intake. Guidelines support assessing nutritional markers as part of this evaluation 3.
Soon, if the pattern has persisted. Stools that have been pale, greasy, bulky or hard to flush for more than a couple of weeks, especially alongside weight loss, abdominal pain after meals, or fat soluble vitamin levels that are low or falling, are worth discussing with a clinician promptly.
Bring specifics rather than impressions. How long the change has lasted, whether it tracks with fattier meals, what has happened to weight over the past few months, any previous abdominal surgery, any history of pancreatitis or heavy alcohol use, and any recent blood results showing low vitamin D, A or E. That information shapes which test gets ordered first and usually saves a round of appointments.
An abnormal stool test result should never be ignored, and it should never be read as a diagnosis either. It is one input. The clinician decides what it means in context, what imaging or further testing is warranted, and what, if anything, follows. Treatment decisions belong to a licensed provider who has evaluated the individual case.
This article is educational and is not medical advice. Discuss your own results and any treatment with a clinician or licensed provider before acting on them.
Related reading on the blood markers most often checked alongside a stool test is available in the guides to vitamin d, vitamin a and vitamin e.
It checks how much dietary fat is leaving the body undigested instead of being absorbed in the small intestine. Depending on the method, it either counts fat globules under a microscope or measures total fat output over a timed collection. A high result means fat is being lost, not why it is being lost.
No. Floating is usually caused by trapped gas rather than fat. The appearance that matters more is stool that is pale, bulky, oily, leaves a film on the water, or smells distinctly different from usual, especially when that pattern lasts for weeks.
Laboratories generally regard a result above 200 µg/g of stool as normal, 100 to 200 µg/g as indeterminate, and below 100 µg/g as a severe reduction in pancreatic enzyme output. These thresholds vary by laboratory and assay. The number is interpreted alongside symptoms and other test results, never on its own.
Only for the quantitative fat test, which measures total fat output over a timed window on a set fat intake. The fecal elastase test needs a single stool sample with no dietary preparation, which is why it is ordered far more often.
Yes, and this is the most common pitfall. A watery sample dilutes elastase and can push the number into a low range even when the pancreas is working normally. A formed sample gives a more reliable reading, and clinicians often repeat a borderline result on a better sample.
They are droplets of fat seen when a stool smear is stained and examined under a microscope. Reports usually describe them as few, moderate or many per field. The finding is a screen that suggests fat may not be absorbing properly, and it is normally followed by a test that measures something specific.
Follow whatever instructions the laboratory provides, because they differ by test. The single sample elastase test generally needs no dietary change, while a timed fat collection requires a defined fat intake. Do not change your diet on your own beforehand, since that can make the result harder to interpret.
A clinician reviews the result alongside your history, symptoms and blood markers, and decides whether imaging or further testing is warranted. Fat soluble vitamin levels are often checked at the same time to see whether absorption has already affected nutrient status. Any next step, including any treatment, is decided by a licensed provider.